Treatment of treatment-resistant autoimmune blistering skin disorders with rituximab.
Jensen
A Ø
AØ
Møller
B K
BK
Vangkilde
A
A
Mark
B
B
Obitz
E R
ER
Kragballe
K
K
Iversen
L
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D003879:Dermatologic Agents; D000069283:Rituximab